The B sample of Mohammad Asif, the Pakistan fast bowler, taken during the Indian Premier League has tested positive for a banned substance, AFP has reported. Last month the IPL had revealed that Asif had tested positive in random testing conducted during the tournament. Asif, who played for the Delhi Daredevils, had asked for his B sample to be analysed.
The second sample had 5.4 mg of nandrolone while the first had 6.2 mg, has learnt. Asif, who faces a possible two-year ban, and his lawyer have questioned this discrepancy. "I can only confirm the B sample test has come positive but the results of both tests are different which is strange to us," Shahid Karim, Asif's lawyer, told PTI. Asif, who was in Geneva for the analysis along with his lawyer, indicated he might appeal against the result. "They took my urine samples at the same time in the IPL and the tests have shown up different results," he said. "That certainly makes my case stronger."
Asif had been suspended by the PCB from all forms of the game pending the result of the IPL inquiry. Lalit Modi, the IPL commissioner, had previously that if Asif's B sample also tests positive, the matter will be taken up by the IPL's drugs tribunal, comprising Sunil Gavaskar, Dr Ravi Bapat (ex-vice chancellor of Maharashtra University of Health Sciences) and lawyer Shirish Gupte. The tribunal will take a decision in accordance with the ICC's anti-doping code, which the IPL had adopted.
Besides testing positive during the IPL, Asif is also embroiled in another mess, having been detained at Dubai airport in June for allegedly possessing drugs. Asif was released by authorities after 19 days in detention, but an internal inquiry by the Pakistan board had reportedly found the evidence to be "pretty conclusive" against the player, and had recommended a ban.
The fast bowler previously tested positive for nandrolone, the banned anabolic steroid, along with Shoaib Akhtar, just before the 2006 Champions Trophy in India. Though he was banned for one year by a PCB tribunal, the punishment was overturned a month later on appeal.